Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infrared Fluorescence Guided Surgery for Sentinel Node Identification in Cutaneous Melanoma
NCT02142244Unknown
- Sponsor
- Hospital de Amor
- Start
- May 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in cutaneous melanoma (CM), sponsored by Hospital de Amor. Primary endpoint: Sensibility of the sentinel node biopsy. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT02142244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142244.